Thurs 26 August 2021 – ACBC Victoria successfully concluded the five-part Australia-China Science Series with Australia’s national science agency, CSIRO – Unlocking Biotechnology Opportunities for Health.
Expert speakers Dr Helmut Thissen, Dr Judy Scoble from CSIRO and Jeff Malone, CEO of BioMelbourne Network addressed the pioneering and impactful work undertaken in Victoria in the biotechnology and health sector.
Notions of ‘partnering’ and ‘consortium’ were forefront of all speakers’ presentations. Emphasis was placed on the unique and valuable positioning of Victoria’s vibrant MedTech, health tech and diverse research ecosystem. Judy highlighted the efficacious work of her team to get from ‘virus to vaccine’ in just six months, a tremendous effort requiring a consortium of people working around the clock.
Australia’s consistently high rankings in global biomedical research and Melbourne’s No. 4 world standing in health tech ecosystems provides a fertile hotbed for investment and collaborative efforts with global partners including the Chinese Academy of Science (CAS), on such critical issues as COVID-19 detection and intervention.
Supported with significant state and federal government support, strong IP laws, well-established paths to manufacturing, and a strong partnership mindset – the future looks bright for Australia-China research collaboration in the health science sector – indeed, in the broader science relationship, which we hope to have highlighted through this series.